Kisqali 200mg Tablets Online At Best Price In Pakistan

Generic: Ribociclib 200mg

Manufacturer: Novartis Pharma (Imported)

Quantity:

63 Tablets per pack

INDICATION:

 Kisqali 200mg is indicated for adults with hormone receptor (HR)-positive, HER2-negative advanced or metastatic breast cancer, used in combination with an aromatase inhibitor or fulvestrant. It is also approved as adjuvant therapy for HR-positive, HER2-negative stage II and III early breast cancer at high risk of recurrence, again in combination with an aromatase inhibitor. Kisqali helps slow tumor progression, reduce recurrence risk, and improve patient survival. The therapy is tailored by oncologists and often monitored alongside hormonal treatments. It is used in carefully scheduled cycles to maximize efficacy while monitoring tolerability.

MECHANISM OF ACTION:

 Ribociclib is a selective cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitor. In HR-positive breast cancer, CDK4/6 drives progression from the G1 to S phase of the cell cycle by phosphorylating the retinoblastoma protein (pRb). Ribociclib inhibits CDK4/6 activity, blocking pRb phosphorylation, which arrests cancer cells in the G1 phase. This inhibits tumor cell proliferation, reduces tumor growth, and enhances the efficacy of concurrent hormonal therapy.

DOSAGE AND ADMINISTRATION:

●     Adults: 600mg (three 200mg tablets) once daily for 21 consecutive days, followed by 7 days off, in a 28-day cycle.

●     Adjuvant early breast cancer: 400mg daily in the same 21/7 schedule for up to 3 years.

●     Take tablets at the same time each morning, with or without food.

●     Do not crush or split tablets.

●     Dose adjustments may be needed based on toxicity or adverse reactions.

SIDE EFFECTS:

●     Common: neutropenia, nausea, fatigue, diarrhea, alopecia, headache, constipation, infections.

●     Serious: severe neutropenia, QTc prolongation, hepatotoxicity, interstitial lung disease/pneumonitis.

●     Monitoring: regular blood counts, liver function tests, and ECG are mandatory.

NOT RECOMMENDED IN:

●     Known hypersensitivity to ribociclib.

●     Pregnancy (effective contraception required).

●     Breastfeeding.

●     Caution in hepatic impairment or electrolyte abnormalities.

DRUG INTERACTIONS:

 Kisqali interacts with strong CYP3A4 inhibitors like ketoconazole, ritonavir, or clarithromycin, which may increase ribociclib plasma levels and toxicity. Strong CYP3A4 inducers like rifampicin and phenytoin reduce its effectiveness. Concomitant use with QTc-prolonging drugs can increase cardiac risk. Grapefruit and grapefruit juice should be avoided, as they may alter drug metabolism and efficacy. Always consult an oncologist before combining with any other medications or supplements.

WHERE TO BUY:

 Buy Kisqali 200mg Tab online in Pakistan from Dawa Healthcare Pharmacy with confidence. Check the latest Kisqali 200mg tablets price in Pakistan on our website. Order Kisqali Tab online for secure and verified delivery across Pakistan. Dawa Healthcare ensures all medications are genuine and properly stored. Customer support via WhatsApp is available at all branches for order confirmation, queries, or guidance. Ensure timely delivery and adherence to prescribed therapy with Dawa Healthcare’s reliable online service.